This case presents a possible vaccine adverse event of reactivation (recurrence) of a dormant hepatitis B infection in a young female patient reported after administering the first dose of Pfizer-BioNTech COVID-19 vaccine. This case aims to explore a potential adverse reaction of COVID-19 mRNA vaccine which can reboot the inactive viruses, in this case of hepatitis B infection, due to immunomodulation leading to decreased alloreactivity after vaccination, as no other trigger or cause was found. A young female with history of inactive hepatitis B infection was admitted in the emergency ward of our Hospital with vomiting, fever, and jaundice after receiving the first dose of Pfizer-BioNTech (NY, NY, USA & Mainz, GY) COVID-19 vaccine. Her blood tests confirmed the resurgence of the acute hepatitis B virus infection and accordingly treated with antiviral Tenofovir and other appropriate supportive management. After clinical improvement and regression of liver function test, she was discharged from the hospital.